BioJapan
BioJapan is Asia’s premier partnering event for the international biotechnology industry...
Login / Register
Search
BioJapan is Asia’s premier partnering event for the international biotechnology industry...
PR euroCHEM / SME / Search for Partners in JapanFounded in 1998 in Ireland, PR euroCHEM is...
What should you know when entering Pharmaceutical market in Japan? Various EU products and...
Various EU products and services began to enjoy benefits from the EU-Japan Economic...
Defined by the Pharmaceutical and Medical Devices Act, a "pharmaceutical product" is a medicine that has been approved for the efficacy of its ingredients and is intended to treat a disease.
About the Report: The Japanese market for pharmaceuticals is amongst the largest in the...
About the Report This report titled "The pharmaceuticals industry in Japan: current trends...
In 2012, the size of the Japanese market for nutritional supplements exceeded $7 billion. The single largest selling supplement was vitamin C, and 53 other nutritional supplement products enjoyed sales in excess of $2 billion.
Which opportunities does the Biopharmaceutical market in Japan offer to EU companies?Among...
What business opportunities currently exist for European SMEs seeking to invest in...
How can I access the Japanese market as a novel biopharmaceutical product's owner?Japan...
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
